Study design
Cancer
CANCER
Our study consisted of two phases; the first phase was an exploratory Phase IB component concentrating on safety, and the second consisted of a multicenter, randomized, double-blind Phase II assessment. Our research was conducted at six hospitals, including the Cancer Hospital Chinese Academy of Medical Sciences, and was approved by the ethics committees of all participating institutes (registration number NCT04460066 on clinicaltrials.gov).